CLDX News and Press, Celldex Therapeutics Inc. From 02/24/25

Grupo Aeroportuario del Sureste S.A. de C.V. (ASR) is expected to report $5.54 for Q4 2024 Zoom Communications Inc. (ZM) is expected to report $0.66 for Q4 2025 Toro Corp. (TORO) is expected to report for Q4 2024 Apple Hospitality REIT Inc. (APLE) is expected to report $0.31 for Q4 20...

2025-02-10 14:55:00 ET Summary Celldex's lead molecule, Barzolvolimab, showed positive phase 2 data in treating chronic urticaria, despite the company's history of failed molecules and no approved products. The market reacted negatively to 2024 data drops, possibly due to high dis...

2025-01-14 04:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...